Doctor profile · Federal record
Dr. KATHERINE REYNOLDS, ARNP
Family Nurse Practitioner (CMS: NURSE PRACTITIONER) · Nurse Practitioner · SPOKANE VALLEY, WA
- NPI 1114585346
- Accepts Medicare
- 7 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1212 N PINES RD
SPOKANE VALLEY, WA 992064939
(509) 893-8140 - Mailing address
-
956 E HARTSON AVE APT 2
SPOKANE, WA 992022337
Credentials & registration
- NPI registered
- June 2019 — 7 yrs on file
- Profile last updated
- June 22, 2021
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Washington #AP60969823
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1114585346. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
366
Distinct HCPCS
4
Medicare allowed
$37,003
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 157 | 139 | $107 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 94 | 80 | $151 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 58 | 53 | $76 | |
94618 |
Test for exercise-induced lung stress | 57 | 49 | $28 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 97. This provider delivers 3.8× the peer median.Open Payments
Industry payments received
All-time total
$2,432
Transactions
112
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $506.46 | |
| Actelion Pharmaceuticals US, Inc. | 16 | $386.80 | |
| GlaxoSmithKline, LLC. | 32 | $331.09 | |
| Electromed, Inc. | 8 | $302.44 | |
| United Therapeutics Corporation | 11 | $241.09 | |
| Merck Sharp & Dohme LLC | 4 | $103.85 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $88.99 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74.88 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $70.43 | |
| Mylan Specialty L.P. | 3 | $70.20 | |
| Amgen Inc. | 4 | $67.15 | |
| GENZYME CORPORATION | 3 | $66.48 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56.13 | |
| Grifols USA, LLC | 2 | $46.16 | |
| Philips North America LLC | 1 | $20.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,633
Patients
404
Total drug cost
$3,572,102
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 210 | 47 | $182,995 |
| Stiolto Respimat (Tiotropium Br/Olodaterol Hcl) | Brand | 202 | 44 | $120,244 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 161 | 66 | $6,167 |
| Montelukast Sodium | Generic | 152 | 43 | $2,291 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 134 | 30 | $99,062 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 125 | 29 | $61,653 |
| Opsumit (Macitentan) | Brand | 106 | 16 | $1,354,918 |
| Roflumilast | Generic | 101 | 16 | $16,517 |
| Azithromycin | Generic | 79 | 36 | $674 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 78 | 17 | $43,312 |